Abstract
Introduction
Airway hyper-responsiveness is generally associated with exaggerated bronchoconstriction, a key feature of a number of obstructive airway diseases, including asthma and chronic obstructive pulmonary disease [1, 2] . Airway smooth muscle tone is regulated by actin-myosin interactions through the phosphorylation of the 20 kD regulatory myosin light chain (MLC) [3] , which in turn results from the dynamic balance between MLC kinase and MLC phosphatase activities [3, 4] . Actin-myosin dynamics in fibroblasts, epithelial and airway smooth muscle cells are tightly regulated by the Rho GTPase family members RhoA and Rac1 [5] [6] [7] . In particular, RhoA is involved in the formation and maintenance of stress fibres, which are contractile structures consisting of bundles of actin and myosin filaments that regulate tension development [8] . Moreover, activation of RhoA leads to airway smooth muscle tissue contraction [9, 10] mainly via the inhibition of MLC phosphatase, leading to increased MLC phosphorylation [11, 12] . On the other hand, Rac1 activates p21-activated kinase, which phosphorylates and inhibits MLC kinase, leading to reduced MLC phosphorylation [13, 14] . Hence [15, 16] . # [16] . In fact, PKA phosphorylates several target proteins that regulate airway smooth muscle tone, including MLC kinase and potassium channels [17] [18] [19] . However, using selective inhibitors of PKA, Spicuzza et al . [20] [21] [22] [23] [24] [25] . Two isoforms of Epac (Epac1 and Epac2) have been described and partly characterized with respect to their subcellular localization, structure, and function [21, 26] . Although initially characterized as Rap1-specific guanine nucleotide exchange factors (GEFs) [21, 22] , Epac proteins are also able to activate a number of small GTPases that affect a variety of biological processes [26] . Recent studies using human pulmonary artery endothelial cells show that Epac regulates endothelial integrity and permeability by inhibiting Rho and stimulating Rac [27, 28] . We have recently shown that both Epac1 and Epac2 are expressed in human airway smooth muscle cells [29] . Moreover, using the selective Epac activators in combination with PKA activators and inhibitors, we also demonstrated that both Epac and PKA modulate cytokine release by human airway smooth muscle cells in vitro [29] .
In 
Material and methods

Materials
Rac1 and RhoA pull-down, phosphorylation of VASP/MLC and immunoblot analysis
The amount of activated Rac1 or RhoA was measured with the pull-down technique by using glutathione S-transferase tagged PAK1 or Rhothekin, respectively, as previously described [33, 34] . 
Data analysis
The effects of isoproterenol and the cAMP analogues were expressed as percentages of methacholine-induced tone. The effect of the highest concentration of methacholine used was defined as Emax. Using this Emax, the sensitivity to the different substances was evaluated as pEC50 (-log EC50). All data represent means Ϯ S.E.M. from n separate experiments. The statistical significance of differences between data was determined by a paired or unpaired Student's t-test when appropriate.
Differences were considered to be statistically significant when P Ͻ 0.05.
Results
Epac induces relaxation of guinea pig tracheal smooth muscle preparations
To activate PKA and Epac, we used two well-described cAMP analogues, known for their selectivity towards the distinct cAMP effectors [29, 35] . 6-Bnz-cAMP is a selective activator of PKA, which has been used to unravel PKA signalling in several systems including the airways [36, 37] . An index of PKA activation is the phosphorylation of its specific substrate VASP [38] . (Fig. 2A) . To examine the role of Epac in regulating airway smooth muscle tone, we used the cAMP analogue 8-pCPT-2Ј-O-Me-cAMP, which is a well-recognized Epac selective activator [35, 40] . By means of this compound, novel intriguing functions of Epac in the airways have been unravelled [24, 29, 36, 37] . The methylated structure of 8-pCPT-2Ј-O-Me-cAMP makes it an extremely poor PKA activator and allows for specific discrimination between both cAMP-activated signalling pathways [35, 40] further confirmed by the inability of the Epac activator to increase phosphorylation of VASP (Fig. 2C) Fig. 4A ) and increased GTP-loading of RhoA (P Ͻ 0.01, Fig. 4B [29] . (Fig. 5A) [43] . Inhibition of Rac1 augmented basal MLC phosphorylation (P Ͻ 0.05, Fig. 5C ) which was not further increased by methacholine (Fig. 5C ), in line with the inhibitory effect of methacholine on Rac1 activity (Fig. 4C) (Fig. 6A, Table 1 ), confirming a PKA-independent effect for Epac proteins. Accordingly, activation of Epac did not induce VASP phosphorylation by PKA in human tracheal preparations (Fig. 6C) . As expected, isoprotenerol and PKA activation with 6-Bnz-cAMP did induce phosphorylation of VASP in human airway smooth muscle cells (Fig. 6C and D) (P Ͻ 0.01), which was largely inhibited by co-treatment with selective PKA inhibition using Rp-8-CPT-cAMPS (Fig. 6D) (P Ͻ 0.05 both) .
-pCPT-2Ј-O-Me-cAMPS dose-dependently reduced methacholine-induced tone of guinea pig tracheal open rings (Fig. 2B, Table 1). Of note, sensitivity (pEC50) to phosphodiesterase-resistant Sp-8-pCPT-2Ј-O-Me-cAMPS was significantly greater than that we measured for 8-pCPT-2Ј-O-Me-cAMPS (Table 1). Taken together, these findings clearly show that activation of Epac induces guinea pig airway smooth muscle relaxation independent of PKA.
Epac reduces the phosphorylation of MLC by modulating the Rac1/RhoA balance
Actin-myosin dynamics and airway smooth muscle tone are regulated by phosphorylation of MLC. Therefore, we studied the effect of Epac stimulation on (agonist-induced) MLC phosphorylation in both guinea pig and hTERT airway smooth muscle cells. As expected, treatment with methacholine increased the phosphorylation of regulatory MLC in both guinea pig airway smooth muscle cells (Fig. 3A) (P Ͻ 0.001) and hTERT airway smooth muscle cells (Fig. 3B) (P Ͻ 0.01). Importantly, 8-pCPT-2Ј-O-MecAMP completely prevented the induction of MLC phosphorylation by methacholine in both cell types (P Ͻ 0.01 for guinea pig and
Fig. 3 Activation of Epac inhibits methacholine-induced phosphorylation of MLC. (A) Guinea pig and (B) hTERT-airway smooth muscle cells were stimulated for 30 min. with 100 M methacholine, 300 M 8-pCPT-2Ј-O-Me-cAMP or their combination and MLC phosphorylation (p-MLC) was evaluated by Western blot. p-MLC levels were normalized to ␤-actin. Representative blots for p-MLC and
), whereas Rac1 activation was suppressed, as GTP-loading of Rac1 was reduced compared to basal levels (P Ͻ 0.05, Fig. 4C). Importantly, concomitant activation of Epac with 8-pCPT-2Ј-O-Me-cAMP diminished methacholine-induced stress fibre formation (P Ͻ 0.001, Fig. 4A) as well as GTP-loading of RhoA (P Ͻ 0.01, Fig. 4B), whereas basal RhoA activity was not affected by the Epac activator (Fig. 4A). On the other hand, the impaired Rac1 activity after methacholine treatment was completely prevented by co-treatment with 8-pCPT-2Ј-O-Me-cAMP (P Ͻ 0.05, Fig. 4C). Taken together, these findings indicate that Epac stimulation relaxes methacholine-induced airway smooth muscle tone via shifting the relative activation of RhoA and suppression of Rac1 in such a way that an equilibrium favouring Rac1 is established, which in turn results in a reduced MLC phosphorylation. To confirm that activation of Rac1 by Epac is indeed important for its relaxant properties, guinea pig tracheal rings were incubated overnight with Clostridium difficile toxin B-1470. Toxin B-1470 is known to inhibit Epac substrate GTPases such as Rac1 by monoglucosylation, but not RhoA [42], and therefore can provide insight concerning the relative importance of Rac1 and RhoA regulation by Epac in the methacholine-induced contraction. The effectiveness of toxin B-1470 in inhibiting GTPases in guinea pig tracheae was studied by immunoblotting analysis using a specific antibody against the small GTPase Rac1 that only recognizes the non-glucosylated epitope of Rac1
Overnight treatment of guinea pig tracheal smooth muscle tissue with toxin B-1470 inactivated approximately 50% of total Rac1 (P Ͻ 0.05), as illustrated by the reduced expression of non-glycosylated Rac1
Epac reduces airway smooth muscle tone and MLC phosphorylation in human tracheae
We confirmed our key findings in guinea pig in freshly isolated human airway smooth muscle strips and cells. Western analysis revealed that both Epac1 and Epac2 are constitutively expressed in human tracheal smooth muscle strips (Fig. 6A). Importantly, treatment with the Epac activator 8-pCPT-2Ј-O-Me-cAMP dosedependently reduced methacholine-induced contraction of human tracheal strip preparations (Fig. 6B, Table 1). Treatment with the PKA inhibitor Rp-8-CPT-cAMPS did not affect 8-pCPT-2Ј-O-MecAMP-mediated relaxations
Importantly, methacholine induced a ~3-fold increase of phosphorylation of MLC (P Ͻ 0.001), effect that was completely reversed by co-treatment with 8-pCPT-2Ј-O-Me-cAMP to activate Epac (Fig. 6E) (P Ͻ 0.05). As we observed for guinea pig cells, basal levels of phosphorylated MLC were not affected by 8-pCPT-2Ј-O-
Me-cAMP and no differences were observed in the levels of total MLC for the different treatments (Fig. 6E) . Taken together, these finding demonstrate that activation of Epac proteins induce relaxation of human airway smooth muscle, independent of PKA, by inhibiting agonist-induced MLC phosphorylation.
Discussion
Our study is the first to show activation of cAMP-dependent Epac as a novel signalling effector that promotes relaxation of airway smooth muscle. Here, we demonstrate that Epac activation inhibits contraction of airway smooth muscle from guinea pig and human by a process that is largely independent of PKA. Importantly, we (Fig. 7) . Abnormal regulation of airway smooth muscle tone causes airway hyper-responsiveness, a main feature of obstructive airway diseases such as asthma and chronic obstructive pulmonary disease [2] . The complex mechanisms of airway tone regulation rely on the intrinsic capacity of the airway smooth muscle to contract and to relax providing control of airway lumen diameter and respiratory capacity. The relaxant properties of cAMP-elevating ␤2-agonists are well established [15] , but there is surprisingly little precise knowledge about the molecular mechanisms of cAMP action. Spicuzza et al. [20] of PKA-independent mechanisms of an unknown nature in the isoproterenol-induced relaxation of guinea pig tracheae [20] . [44, 45] . Moreover, they seem able to regulate contractile myofilament function [44] and potassium channels [46, 47] 
